Skip to content

Clinical trials

Completed Hyperoxaluria, Primary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperoxaluria, Primary Status: Completed Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20072
20091
20101
20134
20141
20161
20171
20184
20193
20202
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alnylam Pharmaceuticals5
OxThera5
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company4
Mayo Clinic4
Allena Pharmaceuticals1
Biocodex1
Centre Hospitalier Universitaire de Liege1
NYU Langone Health1
Novo Nordisk A/S1
University of Cologne1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperoxaluria, Primary24
Hyperoxaluria12
Genetic Diseases, Inborn2
Kidney Calculi2
Kidney Diseases2
Urologic Diseases2
Adrenal Hyperplasia, Congenital1
Adrenoleukodystrophy1
Andersen Syndrome1
Anemia, Diamond-Blackfan1

Trials

Showing 26 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.